Medical/Pharmaceuticals
AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
HAMILTON ON, Aug. 24, 2022 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Orga...
2022-08-24 21:00
7243
MGI Supports the Ministry of Health of Indonesia in the Country's Breakthrough National Genome Project
JAKARTA, Indonesia, Aug. 24, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, today announced that the National Genome Project inIndonesia has selected MGI technology* as one of the technology providers for the first phase of its effort towards establishin...
2022-08-24 17:34
4988
Cancer treatment with the world's smallest rotating gantry began at Yamagata University in 2022: Taking on the challenge of global standardization of heavy ion therapy equipment
SINGAPORE, Aug. 24, 2022 /PRNewswire/ -- In the face of fierce competition among major heavy electric machinery manufacturers, Toshiba deliveredJapan's first rotating gantry for heavy ion cancer therapy using superconducting technology to the National Institutes for Quantum Science and Technology...
2022-08-24 10:00
11862
Mangosteen Peel as Medicine - CU's Faculty of Veterinary Science is Successful in Replicating Mangosteen Peel Extract, Treatment for Intestinal Inflammation in Humans and Animals
BANGKOK, Thailand, Aug. 24, 2022 /PRNewswire/ -- The Faculty of Veterinary Science,Chulalongkorn University has researched and replicated "Hydroxy- xanthones", the vital extracts rich in antioxidants found in mangosteen peels that kill germs and halt infections in the intestinal mucosa. It hopes t...
2022-08-24 10:00
3026
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study
GENEVA, Switzerland, Aug. 24, 2022 /PRNewswire/ -- The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the ...
2022-08-24 09:00
4317
Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) in Patients with Advanced Malignancies
ROCKVILLE, Md. and SUZHOU, China, Aug. 23, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2022-08-24 08:00
4761
Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results
Additions to executive team strengthen global leadership and position Company for strategic long-term growth First-ever product launch of long-acting amubarvimab/romlusevimab combination therapy for COVID-19 inChina advances Brii Bio from clinical development to commercial stage biotechnology co...
2022-08-24 07:30
5379
Targeted Alpha Therapy Candidate: Bladder Cancer Study Completes Enrolment
MELBOURNE, Australia and NANTES, France, Aug. 24, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. ('ATONCO') today announced that the final patient has been dosed in a Phase I study of TLX250-CDx in patients with non-muscle invasive...
2022-08-24 05:56
4593
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
LISBON, Portugal, Aug. 23, 2022 /PRNewswire/ -- Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor...
2022-08-23 17:58
2581
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
NANJING, China, Aug. 23, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, announces FDA clearance of its IND application for innovative antibody drug program (SLC-3010). GenScript ProBio was responsible for the CMC development and supporting IND filing in this project. Gen...
2022-08-23 14:15
3601
Announcement of 2022 Future Science Prize Winners: Wenhui Li, Xueming Yang, Ngaiming Mok
BEIJING, Aug. 23, 2022 /PRNewswire/ -- The Future Science Prize committee announces the winners of 2022 onAugust 21st. Prof. Wenhui Li from National Institute of Biological Sciences,Beijing, China; Tsinghua Institute of Multidisciplinary Biomedical Research receives the Future Science Prize in li...
2022-08-23 11:52
3714
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head
Building a leadership team with global and local experience and expertise to
enable rapid execution across Company's broad therapeutic strategy
DURHAM, N.C. and BEIJING, Aug. 23, 2022 /PRNewswire/ -- Brii Biosciences
2022-08-23 07:30
4995
Australians Takes Part in World Blood Donation Record Attempt to Save Lives
Global campaign to save 150,000 lives through 50,000 donations around the world.
SYDNEY, Aug. 23, 2022 /PRNewswire/ -- On Saturday 27 August, Australians will
attempt to break the world record for the most blood donations in one calendar
day.
2022-08-23 06:38
3312
DxGen Corp. and Precision Diabetes, Inc. Announce Strategic Partnership to Launch New Diabetes Point-Of-Care Testing Analyzer into the U.S. Market.
RALEIGH, N.C. and SEOUL, Korea, Aug. 22, 2022 /PRNewswire/ -- Precision Diabetes, Inc. and DxGen Corp. are pleased to announce that they have entered in an exclusive agreement in the U.S. to launch Epithod® AutoDx, a fully-automatic point-of-care (POC) analyzer that measures a comprehensive prof...
2022-08-22 20:00
2707
Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases
Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company's development of ocular tissue rejuvenation therapeutics MOUNTAIN VIEW, Calif., Aug. 22, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA ...
2022-08-22 20:00
3871
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.
ANDERNACH, Germany, Aug. 22, 2022 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS") announces the closing of the acquisition of Tapemark Inc. ("Tapemark") located inSt. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and...
2022-08-22 18:00
2248
The 2022 Smart China Expo kicked off, smart technology empowers Chongqing Liangjiang New Area to lead innovative development
CHONGQING, China, Aug. 22, 2022 /PRNewswire/ -- The 2022 Smart China Expo will be held in Liangjiang New Area of southwest China'sChongqing from August 22 to 24, with the theme of "Smart Technology: Empowering Economy, Enriching Life". As the most influential event in China's intelligent industry...
2022-08-22 15:37
5873
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17
* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can beginonce a policy recommendation from the CDC is received GAITHERSBURG, Md., Aug. 2...
2022-08-22 10:05
5329
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes
HONG KONG, Aug. 22, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or " Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company has been selected as a constituent stock of eight index series including...
2022-08-22 08:33
4134
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA
-- Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA -- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a new and differentiated chemical...
2022-08-22 08:10
3983
Week's Top Stories
Most Reposted
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23754
